A group based on complementary expertise with multidisciplinary know-how

mAbEXperts

A range of integrated biotechnology solutions

A complete platform, from DNA to recombinant antibodies

Custom Products & Services in Biotechnology

Molecular Biology - Immunology - Protein and Cell Engineering

Monoclonal antibodies, Cytokines, Chemokines, CD markers, Apoptosis, Bioactive antibodies, ELISA Kits, ELISpot Kits, DIAplex, Bioassays

go

Custom services, Biomanufacturing and purification, antibodies, recombinant proteins, plasmids, transfection, hybridoma development, expression vectors, FastELISA kits

go

Primary and Secondary Antibodies Anti-species, Isotype controls, custom services, hybridoma development – rat, guinea pig, murine, Immunoassays

go

Effective synergy

As part of a team of experts to ensure:

  • The development of new biological tools in immunology, molecular biology, cellular engineering
  • Identification of new markers
  • The development of analytical methods
  • Scientific and technical support
  • The quality of services and products developed and manufactured in-house

Main sectors of activity

  • Pharmaceutical
  • BioTherapeutics
  • Biotechnology
  • In vitro diagnostics
  • Animal health
  • Dermo-cosmetic
  • Agribusiness
  • Life sciences
  • Environment
  • Research Institutes

News

  • Diaclone ELISpot assays, tried and trusted by researchers worldwide
    Date of publication : 01/04/2021


    Diaclone ELISpots (Enzyme-Linked Immunospot Assays) are highly specific immunoassays for the analysis of cytokine and other soluble molecule production and secretion from T-cells at a single cell...

    Read more
  • Come and join our team!
    Date of publication : 11/03/2021

    As part of the development of its new GMP plasmid production unit, RD-Biotech is recruiting two new profiles:

    - Technician in Molecular Biology Bioproduction

    - Quality Control Manager

    For...

    Read more
  • RD-BIOTECH IS PLEASED TO ANNOUNCE THE SIGNATURE OF A PARTNERSHIP AGREEMENT WITH LUMINEX CORPORATION
    Date of publication : 25/02/2021